Ruban Maxim Sergeevich

Specialization: Specialist in Antitumor Drug Therapy, Oncology, Oncology

Branch: P. Hertsen Moscow Oncology Research Institute (MORI)

Position: oncologist

Department: Отделение персонифицированных биотехнологических методов лечения

Biography

Oncologist and chemotherapist in the Department of Personalized Biotechnological Treatment Methods at the P. Hertsen Moscow Oncology Research Institute (MORI) – branch of the National Medical Research Radiological Centre (NMRRC) of the Ministry of Health of the Russian Federation. He specializes in drug-based antitumor treatment of solid malignancies. Along with his clinical work, he conducts research and participates in clinical trials conducted at the institute.

Work experience:

2024–2025 — Junior Researcher in the Research and Education Department of the P. Hertsen Moscow Oncology Research Institute (MORI) – branch of the National Medical Research Radiological Centre (NMRRC) of the Ministry of Health of the Russian Federation.

2026–present — Oncologist in the Department of Personalized Biotechnological Treatment Methods of the P. Hertsen Moscow Oncology Research Institute (MORI) – branch of the National Medical Research Radiological Centre (NMRRC) of the Ministry of Health of the Russian Federation.

Education

2015 - 2021
medical treatment
Voronezh State Medical University named after N.N. Burdenko of the Ministry of Health of the Russian Federation
2021 - 2023
oncology
Clinical residency, FSBI «NMRRC» of the Ministry of Health of the Russian Federation
2023

postgraduate study, P. Hertsen Moscow Oncology Research Institute (MORI) – branch of the National Medical Research Radiological Centre (NMRRC) of the Ministry of Health of the Russian Federation

Accreditation

онкология

Awards and honors

Has published scientific articles in peer-reviewed Russian and international journals, including first-quartile (Q1) journals. Presents oral and poster presentations at international and Russian oncology conferences, including the ASCO Annual Meeting. Reviewer for Frontiers publishing group journals, including Frontiers in Oncology. Holds a certificate of completion of the “Good Clinical Practice for Investigators (ICH GCP)” training course.